AVCN.TO
Avicanna Inc
Price:  
0.28 
CAD
Volume:  
318,726.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-
Upside

As of 2025-10-20, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -33.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 31.81 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -0.95 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.28 CAD
Stock Price
- CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-10-16 -33.57
2025-10-15 -35.38
2025-10-14 -32.36
2025-10-10 -31.76
2025-10-09 -32.36
2025-10-08 -31.16
2025-10-07 -32.97
2025-10-06 -32.36
2025-10-03 -30.56
2025-10-02 -29.95
2025-10-01 -29.95
2025-09-30 -29.35
2025-09-29 -29.95
2025-09-26 -30.56
2025-09-25 -29.95
2025-09-24 -29.95
2025-09-23 -29.95
2025-09-22 -30.56
2025-09-19 -30.56
2025-09-18 -30.56
2025-09-17 -29.95
2025-09-16 -29.95
2025-09-15 -32.36
2025-09-12 -32.36
2025-09-11 -32.97
2025-09-10 -32.36
2025-09-09 -32.97
2025-09-08 -32.36
2025-09-05 -32.36
2025-09-04 -32.97
2025-09-03 -32.36
2025-09-02 -32.36
2025-08-29 -33.57
2025-08-28 -33.57
2025-08-27 -32.97
2025-08-26 -33.57
2025-08-25 -32.36
2025-08-22 -33.57
2025-08-21 -32.97
2025-08-20 -32.97
2025-08-19 -32.36
2025-08-18 -32.36
2025-08-15 -32.36
2025-08-14 -32.36
2025-08-13 -34.17
2025-08-12 -33.57
2025-08-11 -33.57
2025-08-08 -32.97
2025-08-07 -33.57
2025-08-06 -33.57